LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea · Delayed Price · Currency is KRW 104,300
-9,000 (-7.94%)
Jul 14, 2026, 3:30 PM KST
LigaChem Biosciences Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, LigaChem Biosciences stock has a consensus rating of "Buy" and an average price target of ₩224,286. The average 1-year stock price forecast is 115.04% higher than the current stock price, while the lowest is ₩200,000 (+91.75%) and the highest is ₩240,000 (+130.11%).
Price Target: ₩224,286 (+115.04%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LigaChem Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 3 | 2 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 5 | 6 | 7 | 7 |
Financial Forecast
Revenue This Year
204.07B
from 141.55B
Increased by 44.16%
Revenue Next Year
275.18B
from 204.07B
Increased by 34.84%
EPS This Year
-1.71K
from -2.04K
EPS Next Year
-1.01K
from -1.71K
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 283.1B | ||
| Avg | 204.1B | ||
| Low | 144.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 100.0% | ||
| Avg | 44.2% | ||
| Low | 1.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 723.09 | ||
| Avg | -1,708.40 | ||
| Low | -2,738.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |